A novel series of new ten tolmetin hydrazide derivatives, 
INTRODUCTION
Tolmetin, 2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl] acetic acid is a non-steroidal anti-inflammatory drug. In addition, it has been reported to prevent proliferation of colon cancer cells (1) and inhibit the β-catenin functions (2) . Duffy and co-workers evaluated that tolmetin and other (NSAID)s have effects on increasing the cytotoxic activity of the anti-cancer drugs (3) . Thiosemicarbazides, which are intermediate products of the synthesis for bioactive heterocyclic compounds, have taken attention of the researchers because of their clinical use and diverse biological activities (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (Fig 1) . In this work, we synthesized novel ten tolmetin thiosemicarbazide derivatives (4a-j) and investigated their anticancer activity against cancer cell lines. The characterization of these compounds were identified with the help of elementel analysis, FT-IR, 1 H-NMR, 13 C-NMR and 2D-NMR spectral data while their purities were analyzed by thin layer chromatography (TLC). 
EXPERIMENTAL

Chemistry
Tolmetin sodium was generously provided by Santa Farma Pharmaceuticals (Istanbul, Turkey). All chemicals were purchased from Merck, Sigma-Aldrich, or Fluka. Reactions were monitored by TLC on silica gel plates purchased from Merck. Melting points of the synthesized com pounds were determined in a Thermoscientific IA 9300 melting point apparatus and are uncorrected. The purity of the com pounds was checked on TLC plates precoated with silica gel G using the solvent systems M 1 (petroleum ether/acetone 50:50 v/v), M 2 (petroleum ether/acetone 30:70 v/v). The spots were located under UV light (254 nm) (t = 21 °C). Elemental analyses were performed on a CHNS-932 (LECO). FT-IR spectra were recorded on a Shimadzu FT-IR-8400S spectrophotometer. 1 
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Biological Activity
Cell Treatment: Androjen-independed human prostate cancer cell line PC-3 (ATCC, CRL-1435), human colon carcinoma cell lines HCT-116 (ATCC, CCL-247) , HT-29 (ATCC, HTB-38) and mouse embriyonic fibroblast cell line NIH3T3 (ATCC, CRL-1658) were maintained in Dulbecco modified Eagle's medium (DMEM) supplemented with 10% FBS and 1% penicilin/ streptomycin in the presence of 5% CO 2 in air at 37 °C. Tolmetin and compound 4d were dissolved in DMSO and the cells were treated with increasing doses of compounds for 24 h in 37 °C.
Cell Viability Assay:
Cell viability was determined by the MTT assay method. Briefly, PC-3 cells (1x10 4 cells/well) were seeded into 96-well plates and incubated for 24 h at 37°C in CO 2 incubator. Then, the cells were grown in the absence or presence of increasing doses of tolmetin and compound 4d at 37°C. After 24 h treatment, the media was removed and then 10 μL of MTT (5 mg/mL in phosphate-buffered saline) was added to each well for an additional 4 hours. The precipitated formazan was dissolved in 100 μL of 10 % SDS and the absorbance was taken at 570 nm. The percentage of viability was calculated as the following formula: (viable cells)%=(OD of treated sample/OD of untreated sample)×100.
RESULTS AND DISCUSSION
Synthesis of Tolmetin thiosemicarbazides
Tolmetin, 2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid was chosen as the starting compound to design several novel thiosemicarbazides. As shown in the synthesis scheme (Fig 2) , tolmetin was first synthesized from tolmetin sodium dihydrate by hydrolysing the dihydrate in conditions. Methyl 2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetate [2] has been synthesized from tolmetin [1] with methanol and few drops of concentrated sulfuric acid. 2-[1-Methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetohydrazide [3] was synthesized from compound [2] , which is an ester, with hydrazine hydrate and methanol. N-Alkyl/Arylsubstituted-2-{[1-methyl-5-(4-methylbenzoyl)-1H-pyrol-2-yl]acetyl}hydrazine carbothioamides [4a-j] were synthesized with the reaction of compound [3] and substituted alkyl/aryl isothiocyanates. The synthesized compounds were identifed by FT-IR, 1 H-NMR, 13 C-NMR and 2D-NMR (only 4d) and their purity were proven by elemental analysis and TLC. (15), previously and -NH 2 protones of hydrazide were reported in 4.27 ppm. 1 H-NMR spectrum of the compounds 4a-j proves the dissappearence of -NH 2 protones which belong to -CONHNH 2 functional group. N 1 , N 2 and N 4 protones which prove the presence of thiosemicarbazides were detected in 1 H-NMR spectrum (Fig 3) and the information given is supported by the literature. (17) (18) (19) (20) (21) (22) . 4c, 4e, 4f, 4h) , it was determined that these compounds undergo thione-thiol tautomerism (Fig 4) . In addition, -NH proton of compound 4d was observed to exchange with D 2 O in the spectrum (Fig 5) . Compound 4d was chosen as the prototype for the 13 C NMR spectrum. The presence of C=O and C=S carbons in 13 C-NMR spectrum proves the synthesis of thiosemicarbazide. C=O and C=S peak values can be seen in Fig 6. According to both HMBC and 13 C-NMR data, C=O and C=S peaks were observed at 168 ppm and 161 ppm, respectively. (Fig 6-7) .
Fig 6.
13 C-NMR spectrum data of compound 4d 16 C-NMR spectrum data of compound 4d The results revealed that tolmetin hydrazone showed anticancer activity againts HT-29 colon cancer cell line (dose depended) with IC 50 value of 76 µM. Tolmetin hydrazone was then used in further tests to investigate the apoptotic effect on HT-29 cancer cell line. Apoptosis is known to be an important mechanism of cancer growth and therefore, caspase 3, caspase 8 and caspase 9 enzyme levels were observed in apoptotic pathway. This study proves that tolmetin hydrazone triggers apoptosis using caspase 8 pathway in HT-29 cancer cell line. Prostate cancer is known to be the second cancer disease after lung cancer with the insidance of 24.33/100.000 in our country. It is also reported as a common cancer type in USA and Europe (23) . Demertzi et al. (24) reported the antineoplastic activity of thiosemicarbazones (TSC). TSC can bind the heavy metals with its two nitrogen and one sulphur atom, occuring a triple chelation. TSCs were reported to be strong inhibitors of ribonucleotite reductase (RR) which reduces ribonucletites to deoxyribonucletites (25) . Ribonucleotide reductase is an important enzyme in cell division and tumor growth. TSCs, RR inhibitors, inhibits the DNA synthesis and DNA repair; therefore they show antineoplastic activity. (26, 27) . (Fig 8) . Besides, tolmetin and compound 4d cytotoxicity tests were carried out with NIH-3T3 fibroblast cells (Fig 9) . (30) . ECM has the structue of proteins and proteoglycans. Besides the ability of structural support of the cells, ECM has biological activity on cell proliferation, cell differantiation, migration and adhesion, tissue morphogenesis. Cancer cells use metalloproteinases to get over that barrier. In order to complete invasion or metastasis, cancer cells should destroy the ECM molecules. Matrix metalloproteinases (MMP) are extracellular proteases that consist of 28 different enzymes and responsible for physiological and pathological tissue distruction. These enzymes were first identified by Jerome Gross and Charles Lapiere in 1962 (31) . The destruction of MMP, ECM, can be seen in different physiological and pathological situations (32) . MMPs belong to neutral endopeptidases enzyme family and consist zinc ion, they also have the ability of destroying whole ECM members. Among these members, MMP-2 and 9 levels significantly increase in metastatic prostate cancer (33) These two enzyme levels decrease after the treatment and therefore, they can be evaluated for the efficacy of the treatment. MMP inhibitors pharmacologically are devided into three different groups as peptites and non-peptite collagenlike inhibitors, Tetracycline and Biphosphonates. In early 1980's, the first synthetic MMP inhibitör was developed as pseudopeptite derivative that imitate the collagen structure in MMP seperation area. These inhibitors reversibly bind the MMP's active side. They also create chelation with MMP's active zinc ion with their hydroxamic acid. New molecules are developed from the derivatives of Tetracyclines and they have the ability of inhibiting MMPs rather than showing antibacterial activity. Tetracyclines could be preventing the avidity to zinc atom or they could inhibit the regulation of MMP during the transcription. Metastat (Col-3), minocyclin and doxycycline are the examples of these inhibitors (34). Küçükgüzel and co-workers (16) synthesized N'-[(2,6-dichlorophenyl)methyliden]-2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetohydrazide and found activity againts HT-29 colon cancer cell line with IC 50 value of 76 µM. This information showed, against colon cancer cell line anticancer activiy of tolmetin maintains whereas the thiosemicarbazide molecule from the same compound have no activity againts colon cancer, instead, it shows activity againts prostate cancer cells. We can conclude that, the electrophilic compounds in the cell bind the sulphur atom in the molecule. Furthermore, thiosemicarbazide may be creating a chelation with the zinc ion in the metalloproteinease enzyme as M. Öncel reported before (34) . (Fig 10) . Anahtar kelimeler: Apoptoz, tolmetin, tiyosemikarbazit, PC-3, kolon kanser.
